BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3964537)

  • 1. The clinical significance of flow cytometric c-myc oncoprotein quantitation in testicular cancer.
    Watson JV; Stewart J; Evan GI; Ritson A; Sikora K
    Br J Cancer; 1986 Mar; 53(3):331-7. PubMed ID: 3964537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of the c-myc oncogene product in testicular cancer.
    Sikora K; Evan G; Stewart J; Watson JV
    Br J Cancer; 1985 Aug; 52(2):171-6. PubMed ID: 4027160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simultaneous flow cytometric assay for c-myc oncoprotein and DNA in nuclei from paraffin embedded material.
    Watson JV; Sikora K; Evan GI
    J Immunol Methods; 1985 Oct; 83(1):179-92. PubMed ID: 3902971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric quantitation of the c-myc oncoprotein in archival neoplastic biopsies of the colon.
    Watson JV; Stewart J; Cox H; Sikora K; Evan GI
    Mol Cell Probes; 1987 Jun; 1(2):151-7. PubMed ID: 3331172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenes and germ cell tumours.
    Sikora K; Evan G; Watson J
    Int J Androl; 1987 Feb; 10(1):57-67. PubMed ID: 2438233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical appraisal of the immunohistochemical detection of the c-myc oncogene product in colorectal cancer.
    Jones DJ; Ghosh AK; Moore M; Schofield PF
    Br J Cancer; 1987 Dec; 56(6):779-83. PubMed ID: 3325094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric quantitation of DNA and c-myc oncoprotein in archival biopsies of uterine cervix neoplasia.
    Hendy-Ibbs P; Cox H; Evan GI; Watson JV
    Br J Cancer; 1987 Mar; 55(3):275-82. PubMed ID: 3552016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric and immunohistochemical analysis of p62c-myc oncoprotein in the bronchial epithelium of lung cancer patients.
    Sundaresan V; Reeve JG; Wilson B; Bleehen NM; Watson JV
    Anticancer Res; 1991; 11(6):2111-6. PubMed ID: 1776848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-myc oncoprotein levels in bladder cancer.
    Masters JR; Vesey SG; Munn CF; Evan GI; Watson JV
    Urol Res; 1988; 16(5):341-4. PubMed ID: 3059654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of myc family oncogenes in primary human testicular cancer].
    Misaki H; Shuin T; Yao M; Kubota Y; Hosaka M
    Nihon Hinyokika Gakkai Zasshi; 1989 Oct; 80(10):1509-13. PubMed ID: 2601223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenes.
    Sikora K
    Scand J Gastroenterol Suppl; 1985; 117():1-8. PubMed ID: 3868020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
    Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
    Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of the c-myc oncoprotein in human glioblastoma cells and tumor tissue.
    Engelhard HH; Butler AB; Bauer KD
    J Neurosurg; 1989 Aug; 71(2):224-32. PubMed ID: 2545843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of the c-myc oncogene product in colonic polyps and carcinomas.
    Stewart J; Evan G; Watson J; Sikora K
    Br J Cancer; 1986 Jan; 53(1):1-6. PubMed ID: 3511934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
    Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
    Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-myc oncogene product expression and prognosis in operable breast cancer.
    Locker AP; Dowle CS; Ellis IO; Elston CW; Blamey RW; Sikora K; Evan G; Robins RA
    Br J Cancer; 1989 Nov; 60(5):669-72. PubMed ID: 2679850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-myc protein product is a marker of DNA synthesis but not of malignancy in human gastrointestinal tissues and tumours.
    Rew DA; Taylor I; Cox H; Watson JV; Wilson GD
    Br J Surg; 1991 Sep; 78(9):1080-3. PubMed ID: 1933191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-myc oncogene product P62c-myc in ovarian mucinous neoplasms: immunohistochemical study correlated with malignancy.
    Polacarz SV; Hey NA; Stephenson TJ; Hill AS
    J Clin Pathol; 1989 Feb; 42(2):148-52. PubMed ID: 2921356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of c-myc in non-malignant and pre-malignant gastrointestinal disorders.
    Ciclitira PJ; Macartney JC; Evan G
    J Pathol; 1987 Apr; 151(4):293-6. PubMed ID: 3295155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of c-myc oncoprotein represents a new prognostic marker in cutaneous melanoma.
    Ross DA; Wilson GD
    Br J Surg; 1998 Jan; 85(1):46-51. PubMed ID: 9462382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.